This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Americans in 33 states and the District of Columbia have legal access to medical marijuana under a doctor’s authorization. But this same access is often lacking for many military veterans. That is because the current policy of the U.S. Department of Veterans Affairs explicitly prohibits V.A.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. This growth has allowed for the creation of new jobs, increased access to cannabis for consumers, and shows the State’s commitment to social equity in its cannabis programs.”
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”
DUBLIN–(BUSINESS WIRE)–The “Global Psychiatry Partnering 2014-2021: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Trends in Psychiatry dealmaking in the biopharma industry since 2014. Trends in Psychiatry dealmaking in the biopharma industry since 2014.
“New Frontier Data was the first firm to identify and address the need for data in what is now a global cannabis market. We have spent over five years building the only cannabis Big Data technology platform that is able to ingest, scrub, process and report millions of data points.”
Jeffrey Singer, Jacob Rich, Michael Schemenaur, and Robert Capodilupo decided to assess the findings of a study published in 2014 in the American Journal of Public Health that found no correlation between legalized cannabis and risks of mental illness or suicide. We found that recreational marijuana access was associated with a 6.29
In 2014, Governor Jay Nixon signed the Missouri Medical Marijuana Bill, making it possible for CBD to be used as medicine for seizures. Even though laws were put into place that legalized MMJ and made it possible for qualifying patients to access the medication, dispensaries and sales had not yet come into play.
The Legal Aid Society, an organization offering pro bono legal assistance to New York City’s most marginalized communities, is calling attention to new NYPD data showing that 94 percent of all cannabis arrests in 2020 targeted people of color. View original article.
According to quarterly data presented by the US Treasury Department, over 800 banks and credit unions have filed paperwork with the United States government to state their relations with cannabis businesses. This hurdle has historically prevented the big traditional banks in the country from investing in the industry.
Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.
His views were creative and nuanced, data-driven and humanitarian. Our Seattle lawyers have distinct memories of watching Kleiman serve as Washington’s appointed “Pot Czar” as it built out the first state cannabis program in 2014. Kleiman was probably the most influential scholar on cannabis policy. Which Drugs Should be Legalized?
Furthermore, a 2014 meta-analysis reported that the prevalence of pain was 59.2% Cancer Pain Relief With Cannabis: What the New Study Shows Utilizing data from the Quebec Cannabis Registry in Canada, researchers sought to examine the safety and effectiveness of cannabis in addressing cancer pain.
They have data and reports in play and we presume have fairly healthy numbers in terms of B to B clients. said New Frontier Data Founder and CEO Giadha Aguirre de Carcer. based New Frontier Data was founded in 2014 and has grown to over a 50-person team, with three offices in the United States and Europe. Washington, D.C.-based
Founded in 2014, Canadians for Fair Access to Medical Marijuana (CFAMM) (Canadiens pour l’accès équitable à la marijuana médicale (CAEMM)) is a federal non-partisan, non-profit, patient-run organisation dedicated to protecting and improving the rights of medical cannabis patients. Canadian’s for Fair Access to Medical Marijuana .
In Chicago, where medical marijuana has been legal since 2014, and recreational marijuana has been legal for just over a month, people from many facets of the real estate industry — brokers, architects, contractors, real estate owners — came to learn about the new opportunities and pitfalls of the cannabis industry.
On February 22, 2012, the Welfare Integrity and Data Improvement Act (Title IV of Public Law 112-96) was enacted, requiring that States prevent welfare recipients from accessing cash welfare benefits electronically in liquor stores, casinos, and strip clubs. BACKGROUND.
“With hundreds of thousands of cannabis chemotypes analyzed, we’re able to deliver client data that provides insights and tools for chemometric classification and product development. SC Labs customers will gain benefits with access to the most comprehensive industry-forward testing solutions in North America. About SC Labs.
The report, released this month, provides a wide array of data points detailing how legalization has affected law enforcement and marijuana use among Colorado residents. The report also found a notable spike in cannabis use among adults––perhaps not a surprise given the greater accessibility after the change in law. “In In 2019, 19.0
Furthering the mystery of the cannabis-induced munchies, adults with safe, reliable access to legal recreational-cannabis spend more money on cookies, ice cream, and chips than their counterparts, according to a new study. The retail-data analysis covered more than 2,000 counties over a period of a decade, from 2006 to 2016.
As recently as 2014, the vast majority of medical and recreational cannabis sold in Colorado was flower and only 11% was the high-potency concentrates consumed through dab rigs or vape pens. They don’t make cannabis products like they used to, and there’s an increasing number of Colorado lawmakers who think that’s problematic.
Founded in 2014, MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS) a 501(c)(3) nonprofit. MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment. More information about the organization is available at [link].
Legal access to marijuana is associated with a decline in the sales of over-the-counter (OTC) sleep aid medications, according to a new study published in the journal Complementary Therapies in Medicine. – The negative association between cannabis access and sleep aid sales suggests a consumer preference for cannabis.
For the study researchers “included data from people in 2 prospective cohorts. who reported major or persistent pain from June 1, 2014, to December 1, 2017” In total 1,152 people were examined. However, there is a lack of research using individual-level data to explore this question. Methods and findings.
At that time, several states already allowed qualified patients to access and use marijuana for medicinal purposes, but as a regulator, I would not have considered the banking challenges of the cannabis industry to be at the top of my list of concerns. .” Of course, that’s assuming I would have been invited in the first place.
The vote came after a roughly 1 1/2 -hour hearing where the council heard primarily from proponents of the ban who argued that the adverse social effects of making the drug easier to access would outstrip any revenue generated from its sale. Councilors Temple Lentz, Julie Olson and John Blom voted in favor of lifting the ban.
They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. It seems as though research on cannabis and cannabinoids is taking such large strides that it even surpasses research growth in other fields.
Researchers collected data from the 2019-2020 National Health and Resilience in Veterans Study, a national survey that asks veterans to self-report their physical and mental health as well as their recent substance use. An analysis of the survey data revealed that 11.9 percent of veterans had used cannabis within the past six months.
Medical cannabis producers in the state had requested tax refunds in 2014 and in 2018 but the state Taxation and Revenue Department had denied those claims. New Mexico launched its medical cannabis program in 2007 and, as of January, the program had more than 130,340 enrolled patients, according to state Department of Health data.
Deal size aside, we wanted to share what we look at on the data side when a public company or MSO announces a deal. Curaleaf LLC began cultivating and processing medical cannabis in Connecticut in 2014. Cannacurio is a weekly column from Cannabiz Media featuring insights from the most comprehensive license data platform.
Multiple sclerosis qualifies one for getting access to medical cannabis in some states in the US. However, not all patients respond to these treatments well enough, and some don’t respond at all. Scientific research on cannabis and MS. In Canada, patients suffering from MS are eligible for becoming medical cannabis users.
Green Flower and Climb Credit Improve Affordability, Accessibility for Cannabis Career Training as Need for Skilled Workers Grows. Green Flower has long been searching for the right partner to bring simple, affordable, accessible financing options to prospective students at all of our higher education programs across the country.
By getting a medical card, you will be able to access marijuana for medical purposes. Cannabis use, employment, and income: fixed-effects analysis of panel data. Cannabis use, employment, and income: fixed-effects analysis of panel data. 3] Feingold, D., Goor-Aryeh, I., Delayahu, Y., & Lev-Ran, S. … Continue reading.
Governor Tim Walz just signed legislation into law that allows medical patients to access flower instead of just extracts or non-smokables. . Previously, Minnesota was only one of a few medically legal states that still did not allow patients to access flower medicine. . In the House, the bill passed 77 to 57, a close margin.
High Tide gains access to DankStop’s more than 200,000 email subscribers and further bolsters its online presence by gaining access to DankStop’s almost 335,000 Instagram followers. Information on the Company and its many products can be accessed through: www.DankStop.com. Traffic data provided by Google Analytics.
entitled “ The IRS Is Using Its Big Data and Reminds Us and Its Agents That They Have Access to Records of Large Cash Transactions at Financial Institutions “. The IRS has recently provided interim guidance to clarify actions IRS Examiners musttake to analyze and document Currency Transaction Report (CTR) data during an audit.
Medical marijuana in New York has been legal since legislation for the Compassionate Care Act was passed in June of 2014. This has given residents of the state access to the relief that MMJ can provide for a plethora of different conditions. MMJ In New York. All medical marijuana purchases are also added to the PMP database.
is a publicly traded company investing in the medical and recreational cannabis space since 2014. It is the Company’s aim, through its investment in CTL, to develop the most effective cannabis strains (cultivars) specific to pain, nausea, epilepsy and PTSD, solving the critical need for clinical data to support medical marijuana claims.
The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms. Research is ongoing, but the existing data and anecdotal reports show potential. Multiple sclerosis.
Since 2014 when sales began in Colorado and Washington, legalization policies have provided states a new revenue stream to bolster budgets and fund important services and programs. Washington’s voters also approved an adult-use measure in November 2012, and its first stores opened in July 2014. Here’s what they say. 46,104,922.
As marijuana reform continues to blitz through South America, questions about marijuana – from medical access to legalization – are on the minds of voters and politicians alike. In fact, Marijuana Business Daily reports that the number of medical cannabis authorizations in the country surpassed 10,000 since the program’s launch in 2014.
CLARA uses natural language processing to perform contextual analysis, incorporating structured, semi-structured and unstructured data into its AI analysis. The Insurance Institute for Highway Safety (IIHS) recently published data indicating that nearly 9% of crash fatalities are the result of distracted driving. million to $54.3
We compare biennial high school student self-reported survey data from Montevideo and regions in the interior of Uruguay post-legalization (2014–2018) and post initial implementation (2015–2018) to a synthetic counterfactual constructed using a weighted combination of 15 control regions in Chile.”
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.
A 2014 open study of Delta-9-THC found that “THC caused significant improvements in PTSD.” ” The efforts of Senator Savino and others proved unsuccessful, but an agreement was reached for a review 18 months after the program’s July 2014 signing. The Potential Impact and Future of NY’s Medical Cannabis Policy.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content